Caxton Associates (New York)’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $1.6M | Sell |
|
|||||
|
2024
Q3 | $2.22M | Buy |
|
|||||
|
2024
Q2 | $738K | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $1.49M | Buy |
|
|||||
|
2023
Q2 | $1.54M | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $147M | Buy |
|
|||||
|
2022
Q3 | $125M | Sell |
|
|||||
|
2022
Q2 | $151M | Sell |
|
|||||
|
2022
Q1 | $150M | Buy |
|
|||||
|
2021
Q4 | $141M | Buy |
|
|||||
|
2021
Q3 | $63.7M | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $473K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $367K | Buy |
|
|||||
|
2014
Q2 | – | Sell |
|
|||||
|
2014
Q1 | $3.21M | Buy |
|